z-logo
open-access-imgOpen Access
Primary cardiac amyloidosis.
Author(s) -
И. В. Демко,
L. I. Pelinovskaya,
И. А. Соловьева,
А. Yu. Kraposhina,
Н. В. Гордеева,
В. А. Мосина
Publication year - 2018
Publication title -
kliničeskaâ medicina
Language(s) - English
Resource type - Journals
eISSN - 2412-1339
pISSN - 0023-2149
DOI - 10.18821/0023-2149-2017-95-11-971-976
Subject(s) - amyloidosis , cardiac amyloidosis , amyloid (mycology) , medicine , pathology , gold standard (test) , al amyloidosis , biopsy , disease , immunology , immunoglobulin light chain , antibody
Cardiac amyloidosis - the disease which is characterized by deposition of insoluble protein amyloid in intercellular space is one of the most severe implications of systemic amyloidosis. Primary cardiac amyloidosis possesses a wide range of clinical implications that complicates well-timed diagnostics and, respectively, treatment. The long latent current and the adverse forecast do extremely important diagnostics of cardiac amyloidosis at early stages of a disease. The modern concept of pathogenesis and morphology of an amyloidosis is covered in article, the clinical options of a current, diagnostic methods of dysfunction of heart including bio- and immunochemical blood analysis and urine, a complex of tool methods of a research and «the gold standard» of verification of deposits of amyloid - a biopsy of various organs and tissues are described.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here